Jennifer Villasenor-Park, MD/PhD
Associate Professor of Clinical Dermatology
Attending Physician, Hospital of the University of Pennsylvania
Associate Medical Director, Perelman Center
Department of Dermatology
University of Pennsylvania
Department: Dermatology
Contact information
1000 Floral Vale Boulevard
Suite 100
Yardley, PA 19067
Suite 100
Yardley, PA 19067
Education:
B.A. (Molecular and Cellular Biology; Psychology)
University of California at Berkeley, 1999.
Ph.D.
Harvard Medical School, 2007.
M.D.
Harvard Medical School, 2009.
Permanent linkB.A. (Molecular and Cellular Biology; Psychology)
University of California at Berkeley, 1999.
Ph.D.
Harvard Medical School, 2007.
M.D.
Harvard Medical School, 2009.
Selected Publications
Baron J, Chelius M, Cohen L, Perez CC, Riina M, Ramesh S, Tierney A, Elghawy O, Hossain NM, Rook A, Villasenor-Park J, Samimi S, Kim E, Hubbeling H, Plastaras JP, Barta SK, LaRiviere M.: Standard Versus Hypofractionated Low-Dose Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma: A Single Institution Retrospective Analysis. Pract Radiat Oncol S1879-8500(26): 00118-9, April 2026.Jonathan A Baron, Leah Cohen, Monica Chelius, Ian Messing, John Mallon, Ann Tierney, Omar Elghawy, Nasheed Hossain, Alain Rook, Jennifer Villasenor-Park, Sara Samimi, Ellen Kim, Harper Hubbeling, John P Plastaras, Stefan K Barta, Michael LaRiviere: Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma. Clin Lymphoma Myeloma Leuk S2152-2650(26), March 2026.
Omar Elghawy, Colin Thomas, Daniel Gao, Jordan Carter, Daniel Landsburg, Jakub Svoboda, Elise Chong, Ellen Kim, Alain Rook, Jina Chung, Jennifer Villasenor-Park, Carmela Vittorio, John Plastaras, Michael Lariviere, Harper Hubbeling, Sunita Dwivedy Nasta, Stephen Schuster, Stefan Barta: Outcomes in octo- and nonagenarians treated with mogamulizumab-based regimens for cutaneous T-cell lymphoma. Blood 146(Supplement 1), November 2025.
Colin Thomas, Jina Chung, Daniel Landsburg, Sunita Dwivedy Nasta, Jakub Svoboda, Elise Chong, Stephen Schuster, Jordan Carter, Michael Cook, Emily Tomasulo, Omar Elghawy, Michael Lariviere, Harper Hubbeling, John Plastaras, Jennifer Villasenor-Park, Caroline Myers, Marco Ruella, Alain Rook, Ellen Kim, Stefan Barta: Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden. Blood 146(1), November 2025.
Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK: Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 92(3): 634-36, Mar 2025.
Villasenor-Park J, Chung J, Kim EJ: Cutaneous B-Cell Lymphomas. Hematol Oncol Clin North Am 38(5): 1111-31, Oct 2024.
Himeles JR, Holton J, Vittorio C, Rook AH, Haun P, Villasenor-Park J, Samimi S, Kim EJ: Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma. J Am Acad Dermatol 88(3): 680-83, Mar 2023.
Villasenor-Park J, Kim E: Chapter 113: Sezary Syndrome in "Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment. McGraw-Hill LLC. McGraw-Hill LLC, Page: 502, 2023.
Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS: Usage and safety of topical tacrolimus in patients with mycosis fungoides. Clin Exp Dermatol 47(6): 1200-01, Jun 2022.
Xu Z, Margolskee E, Villasenor-Park J, Rubin AI, Khurana MC: A healthy 16-year-old boy presenting with multifocal asymptomatic subcutaneous nodules. Pediatr Dermatol 39(1): E8-E10, Jan 2022.